BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8546415)

  • 1. Plasmid vectors as anti-viral vaccines.
    Ertl HC; Verma P; He Z; Xiang ZQ
    Ann N Y Acad Sci; 1995 Nov; 772():77-87. PubMed ID: 8546415
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
    Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
    Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.
    Fu ZF; Rupprecht CE; Dietzschold B; Saikumar P; Niu HS; Babka I; Wunner WH; Koprowski H
    Vaccine; 1993; 11(9):925-8. PubMed ID: 8212838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants.
    Zhu JH; Wang J; Cai B; Zhao W; Zhu Y; Chao R; Chen L; Xue H; Ying BL; Li CP; Hu QL; Sha J; Esposito JJ
    Arch Virol; 1996; 141(6):1055-65. PubMed ID: 8712923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    J Virol; 1998 Mar; 72(3):1790-6. PubMed ID: 9499029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
    Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
    Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to neonatal genetic immunization.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    Virology; 1997 Feb; 228(2):278-84. PubMed ID: 9123835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of rabies in wildlife.
    Winkler WG; Bögel K
    Sci Am; 1992 Jun; 266(6):86-92. PubMed ID: 1585150
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection.
    Ray NB; Ewalt LC; Lodmell DL
    Vaccine; 1997 Jun; 15(8):892-5. PubMed ID: 9234541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
    Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
    Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization against viral proteins with naked DNA.
    Ulmer JB; Donnelly JJ; Deck RR; DeWitt CM; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():117-25. PubMed ID: 8546384
    [No Abstract]   [Full Text] [Related]  

  • 14. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
    Ge J; Wang X; Tao L; Wen Z; Feng N; Yang S; Xia X; Yang C; Chen H; Bu Z
    J Virol; 2011 Aug; 85(16):8241-52. PubMed ID: 21632762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production of monoclonal antibodies against a wild strain of rabies virus].
    Akacem O; Benmansour A; Coulon P; Brahimi M; Benhassine M
    Arch Inst Pasteur Alger; 1992; 58():283-90. PubMed ID: 1309144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of rabies, using a rec-DNA vaccine.
    Terré J; Chappuis G; Lombard M; Desmettre P
    J Biotechnol; 1996 Apr; 46(2):156-7. PubMed ID: 8672287
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of rabies DNA vaccine using a recombinant plasmid.
    Rai N; Kaushik P; Rai A
    Acta Virol; 2005; 49(3):207-10. PubMed ID: 16178518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
    Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ
    J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of intramuscular immunization with naked DNA.
    Donnelly JJ; Ulmer JB; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():40-6. PubMed ID: 8546412
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of mucosal immunity with a replication-defective adenoviral recombinant.
    Xiang Z; Ertl HC
    Vaccine; 1999 Apr; 17(15-16):2003-8. PubMed ID: 10217600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.